ES2039845T3 - Un procedimiento para preparar nuevos derivados azaciclicos. - Google Patents

Un procedimiento para preparar nuevos derivados azaciclicos.

Info

Publication number
ES2039845T3
ES2039845T3 ES198989301256T ES89301256T ES2039845T3 ES 2039845 T3 ES2039845 T3 ES 2039845T3 ES 198989301256 T ES198989301256 T ES 198989301256T ES 89301256 T ES89301256 T ES 89301256T ES 2039845 T3 ES2039845 T3 ES 2039845T3
Authority
ES
Spain
Prior art keywords
hydrogen
group
alkyl
azaciclic
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198989301256T
Other languages
English (en)
Inventor
Vittorio Vecchietti
Antonio Giordani
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dr L Zambeletti SpA
Original Assignee
Dr L Zambeletti SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr L Zambeletti SpA filed Critical Dr L Zambeletti SpA
Application granted granted Critical
Publication of ES2039845T3 publication Critical patent/ES2039845T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)

Abstract

UN COMPUESTO, O UN SOLVATO O SAL DE ESTO, DE FORMULA (I), EN LA QUE R1 Y R2 SON INDEPENDIENTEMENTE HIDROGENO, C1-6 ALQUILO, C2-6 ALQUENILO, C3-6 CICLOALQUILO O C4-12 CICLOALQUILALQUILO, O JUNTOS FORMAN UN POLIMETILENO C2-8 LINEAL O RAMIFICADO, O UN GRUPO C2-6 ALQUENILENO OPCIONALMENTE SUSTITUIDO CON UN HETEROATOMO, SIEMPRE QUE R1 Y R2 NO SEAN SIMULTANEAMENTE HIDROGENO; R3 ES HIDROGENO, C1-6 ALQUILO, PREFERIBLEMENTE METILO O ETILO, O FENILO, O R3 JUNTO CON R1 FORMA UN GRUPO - (CH2)3 - O - (CH2)4 - P ES 1, 2, 3, 4 Y R ES UN GRUPO DE FORMULA (II), EN LA QUE EL GRUPO - (CHR4)N - X - ESTA EN POSICION META O PARA CON RESPECTO A YR5 O R6, R4 ES HIDROGENO O C1-6 ALQUILO, PREFERIBLEMENTE HIDROGENO; N ES 0,1 O 2 PREFERIBLEMENTE 1; X ES UN ENLACE DIRECTO O O, S O NRA EN LA QUE RA ES HIDROGENO O C1-6 ALQUILO Y ES PREFERIBLEMENTE UN ENLACE DIRECTO; Y ES >C = 0. >CHOH, - S = 0 O - SO2. EL COMPUESTO ES UTIL EN EL TRATAMIENTO DEL DOLOR.
ES198989301256T 1988-02-12 1989-02-09 Un procedimiento para preparar nuevos derivados azaciclicos. Expired - Lifetime ES2039845T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888803259A GB8803259D0 (en) 1988-02-12 1988-02-12 Compounds

Publications (1)

Publication Number Publication Date
ES2039845T3 true ES2039845T3 (es) 1993-10-01

Family

ID=10631593

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198989301256T Expired - Lifetime ES2039845T3 (es) 1988-02-12 1989-02-09 Un procedimiento para preparar nuevos derivados azaciclicos.

Country Status (14)

Country Link
US (1) US4994450A (es)
EP (1) EP0333315B1 (es)
JP (1) JPH01246258A (es)
KR (1) KR890012963A (es)
AT (1) ATE64391T1 (es)
AU (1) AU615984B2 (es)
DE (1) DE68900113D1 (es)
DK (1) DK65489A (es)
ES (1) ES2039845T3 (es)
GB (1) GB8803259D0 (es)
GR (1) GR3002230T3 (es)
NZ (1) NZ227930A (es)
PT (1) PT89677A (es)
ZA (1) ZA891052B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0232612B1 (en) * 1985-12-23 1990-04-04 Dr. Lo. Zambeletti S.p.A. Azacyclic compounds, processes for their preparation, and their use as pharmaceuticals
US5512567A (en) * 1988-08-24 1996-04-30 Sankyo Company, Limited Analgesic compounds, their preparation, and pharmaceutical compositions containing them
DE68924751T2 (de) * 1988-09-26 1996-04-11 Smithkline Beecham Farma Azacyclische Verbindungen, verwendbar als Arzneimittel.
GB8926560D0 (en) * 1989-11-24 1990-01-17 Zambeletti Spa L Pharmaceuticals
EP0447704A1 (en) * 1990-03-21 1991-09-25 Smithkline Beecham Farmaceutici S.p.A. N-Acylated azacyclic compounds, processes for their preparations and their use as medications
WO1991017116A1 (en) * 1990-04-28 1991-11-14 Dr. Lo. Zambeletti S.P.A. Novel 1-(2h-1-oxo-3,4-dihydronaphtyl-6)-acetyl-piperidines, process for their preparation and therapeutic use
GB9011656D0 (en) * 1990-05-24 1990-07-11 Zambeletti Spa L Novel compounds
EP1554572B1 (en) 2001-07-25 2009-10-14 Raptor Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
EP3827747A1 (en) 2005-04-28 2021-06-02 Otsuka Pharmaceutical Co., Ltd. Pharma-informatics system
EP2063905B1 (en) 2006-09-18 2014-07-30 Raptor Pharmaceutical Inc Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
NZ616673A (en) 2009-02-20 2014-08-29 To Bbb Holding B V Glutathione-based drug delivery system
ES2942923T3 (es) 2009-05-06 2023-06-07 Laboratory Skin Care Inc Composiciones de administración dérmica que comprenden complejos de agente activo-partículas de fosfato de calcio y métodos de uso de las mismas
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
CN105299030B (zh) * 2015-11-23 2018-03-23 荣腾实业（苏州）有限公司 一种驱动轴导向机构

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0052311A1 (en) * 1980-11-19 1982-05-26 Sterling Drug Inc. 1-((Benzoylphenyl) - lower-alkyl) piperidines and carbinol analogs and preparation thereof
US4656182A (en) * 1983-12-06 1987-04-07 Warner-Lambert Company Substituted trans-1,2-diaminocyclohexyl amide compounds
DE3409237A1 (de) * 1984-03-14 1985-09-19 Dr. Karl Thomae Gmbh, 7950 Biberach Kondensierte diazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
EP0232612B1 (en) * 1985-12-23 1990-04-04 Dr. Lo. Zambeletti S.p.A. Azacyclic compounds, processes for their preparation, and their use as pharmaceuticals
DE3782191T2 (de) * 1986-06-05 1993-02-25 Ici America Inc Difluorketoverbindungen.
DE3767816D1 (de) * 1986-09-02 1991-03-07 Zambeletti Spa L 1-acylsubstituierte piperidinderivate.
DK674487A (da) * 1986-12-22 1988-06-23 Zambeletti Spa L Piperidinderivater

Also Published As

Publication number Publication date
ZA891052B (en) 1991-03-27
US4994450A (en) 1991-02-19
AU615984B2 (en) 1991-10-17
DK65489D0 (da) 1989-02-10
EP0333315A1 (en) 1989-09-20
DE68900113D1 (de) 1991-07-18
KR890012963A (ko) 1989-09-20
EP0333315B1 (en) 1991-06-12
GR3002230T3 (en) 1992-12-30
JPH01246258A (ja) 1989-10-02
AU2983489A (en) 1989-08-17
GB8803259D0 (en) 1988-03-09
DK65489A (da) 1989-08-13
ATE64391T1 (de) 1991-06-15
PT89677A (pt) 1989-10-04
NZ227930A (en) 1992-05-26

Similar Documents

Publication Publication Date Title
ES2039845T3 (es) Un procedimiento para preparar nuevos derivados azaciclicos.
MX9301457A (es) Agentes antifungicos de peptidos ciclicos y proceso para su preparacion.
SE8202166L (sv) Terapeutiska medel
ES2085259T3 (es) Uso de ciertos antagonistas del receptor 5-ht3 en el tratamiento del dolor visceral.
GR3017213T3 (en) Heterocyclic derivatives.
FI901645A0 (fi) Menetelmä terapeuttisesti aktiivisten interfenyleeni-7-oksabisykloheptyylisubstituoitujen heterosyklisten amidiprostaglandiinianalogien valmistamiseksi
ES545330A0 (es) Un procedimiento para preparar derivados de 1,3-difosfonato
DE3380350D1 (en) Hydroxyalkynyl-azolyl derivatives, process for their preparation and their use as fungicides
ATE42281T1 (de) Verbindungen verwendbar als zwischenprodukte oder ausgangsstoffe zur herstellung von therapeutisch verwendbaren phenyl-azacycloalkanen.
MX11866A (es) Nuevas cicloalquilamidas y procedimiento para su preparacion.
MX168469B (es) Procedimiento para la preparacion de derivados aminoalcoholes acilados
ES2035915T3 (es) Agentes antiarritmicos n-fenetil-aminoalquil-benzamida.
DK560182A (da) Fremgangsmaade til fremstilling af p-substituerede 3-fenoxy-1-karbonylaminoalkylaminopropanol-2-er
ES536218A0 (es) Procedimiento para la obtencion de derivados de hidroxietilazoliloxima
DK544689D0 (da) Terapeutisk aktive forbindelser
NO167575C (no) N-alkyl(en)-n-(o,o-disubstituert-thiofosforyl)-n',n'-disubstituerte-glycinamider, preparater derav med acaricid, insekticid og fungicid virkning, samt fremgangsmaate for kontroll av skadedyr og bekjempelse av sopp.
GR3005138T3 (es)
FR2558161B1 (fr) 3-alkoxy 2-(n-pyrrolidino) n-furylmethyl ou n-thienylmethyl n-pyridyl propylamines, leur preparation et leur application en therapeutique
ES494257A0 (es) Procedimiento para la preparacion de una peptidamida
DE68918726D1 (de) Isocarbacyclinderivate enthaltende Antidiabetika.
IT1213219B (it) Derivati amminoalchilnaftalenici ad attivita' farmacologica.
FI871253A0 (fi) 1-/3-(2-dialkylaminoetoxi)-2 -tienyl/-3-fenyl-1-propanoner och deras syraadditionssalter, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska sammansaettningar.
GB2006196A (en) Phenylacetamides with analgesic activity
ES554301A0 (es) Procedimiento de preparar compuestos amidicos farmacologicamente activos
ZA897953B (en) Branched-chain alkyl esters of 2-(4-(2-piperidino-ethoxy)-benzolyl)-benzoic acid,processes for their preparation and their use as spasmolytic agents

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 333315

Country of ref document: ES